DR Congo Ebola Vaccine Trial to Begin Within Weeks: WHO

The World Health Organization announced that the first clinical trial of an Ebola vaccine is expected to launch in the Democratic Republic of Congo by the end of October. This milestone represents a critical step in developing immunization strategies against the viral hemorrhagic fever that has caused devastating outbreaks across Central Africa. The vaccine trial will evaluate safety and effectiveness in human subjects, potentially providing a breakthrough treatment option. Success in this trial could accelerate vaccine availability for at-risk populations and healthcare workers in affected regions.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: October 14, 2026 at 10:01 AM



